obesity drug news today glp-1 World Health Organization recommends drugs for Dozens of new obesity drugs

The most common cardiovascular (CV) manifestations in patients with type 2 diabetes are heart failure (HF), stable angina, nonfatal myocardial infarction (MI), peripheral arterial disease and ischemic stroke [2,3,4] which accounts for 60% of their deaths [5]

The new pills could make it easier to get the meds into the hands of people who need them, he says

Clinical trials provide free medication access, with over 600 active studies currently available through ClinicalTrials.gov

Interestingly, agmatine, a metabolite produced by the gut bacterium Bacteroides vulgatus was shown to impair ovarian function by inhibiting GLP-1 secretion through activation of the farnesoid X receptor (FXR) (Yun et al., 2024)